Melanoma Institute Australia joins forces with Wollongong Wolves in the fight against melanoma
6 February 2017
The world’s largest melanoma-specific treatment and research facility, Melanoma Institute Australia, is joining forces with the Wollongong Wolves Football Club in the battle to reduce Australia’s melanoma rates.
CEO of Melanoma Institute Australia, Carole Renouf, announced the partnership at a function in Wollongong in support of Wolves’ legend David Cervinski who is battling melanoma.
Ms Renouf said the partnership between MIA and the Wollongong Wolves would help promote sun safe behaviour amongst Wolves’ players and also spread the life-saving message to family and fans.
“It is crucial that young Australians take steps now to protect their skin from sun damage,” Ms Renouf said. “Intense, intermittent sun exposure leading to sunburn, especially before puberty, significantly increases your risk of developing melanoma in the future.
“The real tragedy of melanoma is that it is largely preventable, so we are delighted to be working with the Wollongong Wolves from the grass roots level to change behaviour and save lives.”
CEO of Wollongong Wolves Football Club Chris Papakosmas said, “Partnering with Melanoma Institute Australia is one of the most important sponsorships for our club. Following on from David Cervinski’s recent battles we thought this was a great way to raise awareness.”
One Australian dies from melanoma every six hours. Melanoma is the most common cancer affecting 15-39 year-old Australians and the leading cause of cancer death in 20-39 year-olds. The incidence of melanoma in the over 60s is also high, a legacy of sun-damage from decades ago.
As part of the partnership, Melanoma Institute Australia’s logo will feature prominently on the 2017 jerseys of all Wollongong Wolves juniors. There will also be ongoing education, sun-safety and fundraising campaigns, including the Wolves involvement in MIA’s annual Melanoma March fundraising event at Wollongong’s Stuart Park on Sunday 12 March.
“This partnership is crucial in tackling melanoma head on,” said Ms Renouf. “We are delighted to be working with the Wollongong Wolves and together help end melanoma for future generations.”
Wolves’ fans can join the fight against melanoma by participating in Melanoma March Wollongong on Sunday 12 March. To register, go to www.melanomamarch.org.au
Melanoma research has reached a milestone with the 10,000th patient giving their permission for their blood and tissue samples to be used in the world’s largest melanoma biospecimen bank.
MIA's researchers and clinicians are in Seattle, USA, today sharing their research findings at the prestigious Society of Surgical Oncology’s Annual Cancer Symposium.
Two of the world’s best minds in melanoma have taken over the academic and clinical leadership of Melanoma Institute Australia (MIA). Professor Georgina Long and Professor Richard Scolyer are the new Conjoint Medical Directors of MIA, and are shaping the future direction of melanoma research, treatment and education.
Meet Georgia, our Clinica Nurse Consultant who provides vital care and education for patients throughout their treatment.
Australia, we need to talk. This week’s dramatic episodes of Married At First Sight have highlighted a tragedy which is ripping Australian families apart. Yet no one is talking about it.
To celebrate International Women's Day 2017, MIA shares how some of the women who inspire the way we work every day, are showing their commitment to accelerate gender parity.
We welcome Mr Grant King to the position of Chairman of the Board of Melanoma Institute Australia, following the retirement of Mr Reg Richardson AM who led the organisation for 10 years.
Congratulations to PhD Student, Tuba Nur Gide who was awarded a NSW National Council of Women Australia Day Award for her PhD research work.
Melanoma Institute Australia, is joining forces with the Wollongong Wolves Football Club in the battle to reduce Australia’s melanoma rates.
A new research project will evaluate the benefits and economic implications of CT and PET/CT imaging in patients with asymptomatic Stage III melanoma.
Sunscreen tips for a skin smart summer with the help of Professor Pascale Guitera, Dermatologist Associate for Melanoma Institute Australia.
Although survival rates for people with skin melanoma are increasing, these promises of hope are not being seen in uveal melanoma. Researchers are desperately trying to uncover new ways to treat this disease.
Lucinda Ryan and Carole Renouf talking about melanoma preventation and awareness on 720 ABC Perth.
Research projects led by MIA have been awarded almost $6 million in the latest NHMRC funding round which will enable vital progression of research into melanoma prevention and treatment.
The last decade has seen a surge in therapeutic options for advanced melanoma patients, thanks to research. However, not every patient responds to treatment and researchers are taking on the challenge to find out why.
Our first Global Melanoma Research Report shares selected research from around the world and here at MIA that is making a difference to the lives of melanoma patients now and in the future.
After 18 years as Director of the Sydney Melanoma Unit and then Executive Director of Melanoma Institute Australia, Professor John Thompson AO will step down from the position at the end of 2016.
Australian melanoma clinical practice guidelines have been published on a wiki platform for the first time as researchers try to keep up to date with emerging evidence.
Carole Renouf, CEO of Melanoma Institute Australia is asking young Australians who have been affected by melanoma to share their experiences with her.
Melanoma Institute Australia CEO Carole Renouf wants to make sure Aussies remember to take care of our skin as the festive season draws closer and we spend more time in the sun.